| Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK M Voysey, SAC Clemens, SA Madhi, LY Weckx, PM Folegatti, PK Aley, ... The Lancet 397 (10269), 99-111, 2021 | 5686 | 2021 |
| Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial PM Folegatti, KJ Ewer, PK Aley, B Angus, S Becker, ... The Lancet 396 (10249), 467-478, 2020 | 2940 | 2020 |
| Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial MN Ramasamy, AM Minassian, KJ Ewer, AL Flaxman, PM Folegatti, ... The Lancet 396 (10267), 1979-1993, 2020 | 1763 | 2020 |
| Rational use of face masks in the COVID-19 pandemic S Feng, C Shen, N Xia, W Song, M Fan, BJ Cowling The Lancet Respiratory Medicine 8 (5), 434-436, 2020 | 1730 | 2020 |
| Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four … M Voysey, SAC Clemens, SA Madhi, LY Weckx, PM Folegatti, PK Aley, ... The Lancet 397 (10277), 881-891, 2021 | 1417 | 2021 |
| Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection S Feng, DJ Phillips, T White, H Sayal, PK Aley, S Bibi, C Dold, M Fuskova, ... Nature medicine 27 (11), 2032-2040, 2021 | 1178 | 2021 |
| Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B. 1.1. 7): an exploratory analysis of a randomised controlled trial KRW Emary, T Golubchik, PK Aley, CV Ariani, B Angus, S Bibi, B Blane, ... The Lancet 397 (10282), 1351-1362, 2021 | 766 | 2021 |
| Influenza-associated excess respiratory mortality in China, 2010–15: a population-based study L Li, Y Liu, P Wu, Z Peng, X Wang, T Chen, JYT Wong, J Yang, HS Bond, ... The Lancet Public Health 4 (9), e473-e481, 2019 | 252 | 2019 |
| Potential of the test-negative design for measuring influenza vaccine effectiveness: a systematic review SG Sullivan, S Feng, BJ Cowling Expert review of vaccines 13 (12), 1571-1591, 2014 | 201 | 2014 |
| Safety, immunogenicity, and reactogenicity of BNT162b2 and mRNA-1273 COVID-19 vaccines given as fourth-dose boosters following two doses of ChAdOx1 nCoV-19 or BNT162b2 and a … APS Munro, S Feng, L Janani, V Cornelius, PK Aley, G Babbage, D Baxter, ... The Lancet Infectious Diseases 22 (8), 1131-1141, 2022 | 182 | 2022 |
| The use of test-negative controls to monitor vaccine effectiveness: a systematic review of methodology H Chua, S Feng, JA Lewnard, SG Sullivan, CC Blyth, M Lipsitch, ... Epidemiology 31 (1), 43-64, 2020 | 158 | 2020 |
| Oxford COVID Vaccine Trial Group Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in … M Voysey, SAC Clemens, SA Madhi, LY Weckx, PM Folegatti, PK Aley, ... Lancet 397 (10269), 99-111, 2021 | 145 | 2021 |
| The impact of repeated vaccination on influenza vaccine effectiveness: a systematic review and meta-analysis LC Ramsay, SA Buchan, RG Stirling, BJ Cowling, S Feng, JC Kwong, ... BMC medicine 17, 1-16, 2019 | 100 | 2019 |
| Impact of antibiotic stewardship programmes in Asia: a systematic review and meta-analysis CF Lee, BJ Cowling, S Feng, H Aso, P Wu, K Fukuda, WH Seto Journal of Antimicrobial Chemotherapy 73 (4), 844-851, 2018 | 98 | 2018 |
| Human leukocyte antigen alleles associate with COVID-19 vaccine immunogenicity and risk of breakthrough infection AJ Mentzer, D O’connor, S Bibi, I Chelysheva, EA Clutterbuck, T Demissie, ... Nature medicine 29 (1), 147-157, 2023 | 75 | 2023 |
| Burden of influenza‐associated outpatient influenza‐like illness consultations in China, 2006‐2015: a population‐based study L Feng, S Feng, T Chen, J Yang, YC Lau, Z Peng, L Li, X Wang, ... Influenza and other respiratory viruses 14 (2), 162-172, 2020 | 70 | 2020 |
| The effectiveness of influenza vaccination in preventing hospitalizations in children in Hong Kong, 2009–2013 BJ Cowling, KH Chan, S Feng, ELY Chan, JYC Lo, JSM Peiris, SS Chiu Vaccine 32 (41), 5278-5284, 2014 | 68 | 2014 |
| RETRACTED ARTICLE: The impact of repeated vaccination on influenza vaccine effectiveness: a systematic review and meta-analysis LC Ramsay, SA Buchan, RG Stirling, BJ Cowling, S Feng, JC Kwong, ... BMC medicine 15, 1-18, 2017 | 65 | 2017 |
| Persistence of immunogenicity after seven COVID-19 vaccines given as third dose boosters following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK: Three month analyses of … X Liu, APS Munro, S Feng, L Janani, PK Aley, G Babbage, D Baxter, ... Journal of Infection 84 (6), 795-813, 2022 | 61 | 2022 |
| Influenza vaccine effectiveness by test-negative design–Comparison of inpatient and outpatient settings S Feng, BJ Cowling, SG Sullivan Vaccine 34 (14), 1672-1679, 2016 | 56 | 2016 |
Ben CowlingChair Professor of Epidemiology, School of Public Health, The University of Hong KongVahvistettu sähköpostiosoite verkkotunnuksessa hku.hk